• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱过度活动症的管理。

Management of overactive bladder.

机构信息

Royal Liverpool University Hospital, Liverpool L3 5PS, UK.

出版信息

Nat Rev Urol. 2010 Oct;7(10):572-82. doi: 10.1038/nrurol.2010.147.

DOI:10.1038/nrurol.2010.147
PMID:20930868
Abstract

Many people are affected by urinary urgency, which can be highly bothersome. Urgency is the cornerstone symptom of overactive bladder (OAB), commonly occurring in conjunction with urinary frequency and nocturia. Once other medical causes of similar symptoms have been excluded, first-line OAB management comprises fluid intake advice and bladder training, supplemented by antimuscarinic drugs if necessary. Urodynamic confirmation of the diagnosis is required for OAB patients whose symptoms are refractory to first-line interventions. If patients are severely bothered by OAB despite optimization of medical treatment, they may proceed to invasive treatments, including neuromodulation, enterocystoplasty, detrusor myectomy, or urinary diversion. Our burgeoning understanding of the complex cellular, neural and integrative physiology of the bladder offers new insights into the causative mechanisms of OAB, and reasons why patients sometimes fail to respond to treatment. Study of sensory information pathways in the lower urinary tract has led to identification of the urothelium, afferent nerves and interstitial cells as key cellular elements in OAB. In-depth knowledge of the hierarchy of central nervous system control is lacking, but functional imaging is beginning to elucidate the challenges that lie ahead. New treatments under investigation include botulinum neurotoxin-A injection, oral β(3)-adrenergic agonists, and novel modalities for nerve stimulation. The subjective nature of urinary urgency, the lack of animal models and the multifactorial pathophysiology of OAB present significant challenges to effective clinical management.

摘要

许多人受到尿急的影响,这是非常令人困扰的。尿急是膀胱过度活动症(OAB)的基石症状,通常与尿频和夜尿症同时发生。一旦排除了其他具有类似症状的医学原因,一线 OAB 管理包括液体摄入建议和膀胱训练,如果需要,还可以补充抗毒蕈碱药物。对于对一线干预措施无反应的 OAB 患者,需要进行尿动力学诊断确认。如果患者尽管接受了优化的药物治疗,但仍严重受到 OAB 的困扰,他们可能会接受侵入性治疗,包括神经调节、肠膀胱成形术、逼尿肌切除术或尿流改道。我们对膀胱复杂的细胞、神经和综合生理学的日益了解为 OAB 的致病机制以及为什么患者有时对治疗无反应提供了新的见解。对下尿路感觉信息途径的研究导致发现尿路上皮、传入神经和间质细胞是 OAB 的关键细胞成分。对中枢神经系统控制的层次结构缺乏深入了解,但功能成像开始阐明未来的挑战。正在研究的新治疗方法包括肉毒杆菌神经毒素 A 注射、口服 β(3)-肾上腺素能激动剂以及神经刺激的新方法。尿急的主观性、缺乏动物模型以及 OAB 的多因素病理生理学给有效的临床管理带来了重大挑战。

相似文献

1
Management of overactive bladder.膀胱过度活动症的管理。
Nat Rev Urol. 2010 Oct;7(10):572-82. doi: 10.1038/nrurol.2010.147.
2
Recurrent Urinary Tract Infections in Females and the Overlap with Overactive Bladder.女性复发性尿路感染及其与膀胱过度活动症的重叠
Curr Urol Rep. 2018 Sep 13;19(11):94. doi: 10.1007/s11934-018-0839-3.
3
Pathophysiology of refractory overactive bladder.难治性膀胱过度活动症的病理生理学
Low Urin Tract Symptoms. 2019 Sep;11(4):177-181. doi: 10.1111/luts.12262. Epub 2019 Mar 22.
4
A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment.过度膀胱活跃症病理生理学的全面综述:迈向个体化治疗之路。
Eur Urol. 2019 Jun;75(6):988-1000. doi: 10.1016/j.eururo.2019.02.038. Epub 2019 Mar 26.
5
Overactive bladder: diagnosis and management.膀胱过度活动症:诊断与管理。
Maturitas. 2012 Feb;71(2):188-93. doi: 10.1016/j.maturitas.2011.11.016. Epub 2011 Dec 23.
6
Evaluation and Treatment of Overactive Bladder in Women.女性膀胱过度活动症的评估和治疗。
Mayo Clin Proc. 2020 Feb;95(2):370-377. doi: 10.1016/j.mayocp.2019.11.024.
7
Overactive bladder.膀胱过度活动症。
Maturitas. 2010 Jul;66(3):257-62. doi: 10.1016/j.maturitas.2010.03.010. Epub 2010 Apr 15.
8
Pediatric overactive bladder syndrome: pathophysiology and management.小儿膀胱过度活动症:病理生理学与管理
Paediatr Drugs. 2007;9(6):379-90. doi: 10.2165/00148581-200709060-00005.
9
Urodynamics in the evaluation of overactive bladder.尿动力学在评估膀胱过度活动症中的应用。
Curr Urol Rep. 2010 Sep;11(5):343-7. doi: 10.1007/s11934-010-0130-8.
10
Position statement: a clinical approach to the management of adult non-neurogenic overactive bladder.立场声明:成人非神经源性膀胱过度活动症管理的临床方法。
Med J Aust. 2018 Jan 15;208(1):41-45. doi: 10.5694/mja16.01097.

引用本文的文献

1
Real-time prediction of bladder urine leakage using fuzzy inference system and dual Kalman filtering in cats.利用模糊推理系统和双卡尔曼滤波实时预测猫的膀胱尿液泄漏。
Sci Rep. 2024 Feb 16;14(1):3879. doi: 10.1038/s41598-024-53629-5.
2
Mediterranean Diet and Overactive Bladder.地中海饮食与膀胱过度活动症
Int Neurourol J. 2022 Jun;26(2):129-134. doi: 10.5213/inj.2142118.059. Epub 2022 Jun 30.
3
A general framework for automatic closed-loop control of bladder voiding induced by intraspinal microstimulation in rats.用于大鼠脊髓内微刺激诱导膀胱排空的自动闭环控制的一般框架。

本文引用的文献

1
Potential insights into lower urinary function derived from CNS imaging.源自中枢神经系统成像的下尿路功能的潜在见解。
Neurourol Urodyn. 2010 Apr;29(4):629-33. doi: 10.1002/nau.20916.
2
The cost-effectiveness of solifenacin vs fesoterodine, oxybutynin immediate-release, propiverine, tolterodine extended-release and tolterodine immediate-release in the treatment of patients with overactive bladder in the UK National Health Service.在英国国家医疗服务体系中,索利那新与非索罗定、奥昔布宁速释制剂、丙哌维林、托特罗定缓释制剂和托特罗定速释制剂治疗膀胱过度活动症患者的成本效益比较。
BJU Int. 2010 Aug;106(4):506-14. doi: 10.1111/j.1464-410X.2009.09160.x. Epub 2010 Feb 3.
3
Sci Rep. 2021 Feb 9;11(1):3424. doi: 10.1038/s41598-021-82933-7.
4
Comprehensive Review of Effective Application of Questionnaires for Clinical Research on Lower Urinary Tract Symptoms With Translation and Cultural Adaptation to the Korean Language.《下尿路症状临床研究问卷有效应用的综合综述:韩语翻译与文化调适》
Int Neurourol J. 2020 Dec;24(4):313-323. doi: 10.5213/inj.2040074.037. Epub 2020 Dec 31.
5
A Novel Alternative in the Treatment of Detrusor Overactivity? In Vivo Activity of O-1602, the Newly Synthesized Agonist of GPR55 and GPR18 Cannabinoid Receptors.新型抗逼尿肌过度活动治疗选择?新型 GPR55 和 GPR18 大麻素受体激动剂 O-1602 的体内活性。
Molecules. 2020 Mar 18;25(6):1384. doi: 10.3390/molecules25061384.
6
Association between the Urinary Bladder Volume and the Incidence of "De Novo" Overactive Bladder in Patients with Stress Urinary Incontinence Subjected to Sling Surgeries or Burch Procedure.膀胱容量与吊带手术或膀胱颈悬吊术后压力性尿失禁患者新发“特发性”膀胱过度活动症的关系。
Biomed Res Int. 2019 Feb 12;2019:9515242. doi: 10.1155/2019/9515242. eCollection 2019.
7
Role of the brain stem in tibial inhibition of the micturition reflex in cats.猫脑干在胫神经抑制排尿反射中的作用
Am J Physiol Renal Physiol. 2015 Aug 1;309(3):F242-50. doi: 10.1152/ajprenal.00135.2015. Epub 2015 May 27.
8
Somatic modulation of spinal reflex bladder activity mediated by nociceptive bladder afferent nerve fibers in cats.猫体感觉调制的脊髓反射膀胱活动介导的伤害性膀胱传入神经纤维。
Am J Physiol Renal Physiol. 2014 Sep 15;307(6):F673-9. doi: 10.1152/ajprenal.00308.2014. Epub 2014 Jul 23.
9
Sex differences in the physiology and pharmacology of the lower urinary tract.下尿路生理和药理学中的性别差异。
Curr Urol. 2013 Feb;6(4):179-88. doi: 10.1159/000343536. Epub 2013 Feb 8.
10
Management of lower urinary tract dysfunction in patients with neurological disorders.神经疾病患者下尿路功能障碍的管理
Korean J Urol. 2012 Sep;53(9):583-92. doi: 10.4111/kju.2012.53.9.583. Epub 2012 Sep 19.
Overactive bladder medication adherence when medication is free to patients.
患者免费获得药物时,过度膀胱药物的用药依从性。
J Urol. 2010 Mar;183(3):1077-81. doi: 10.1016/j.juro.2009.11.026. Epub 2010 Jan 21.
4
Neural control of the lower urinary and gastrointestinal tracts: supraspinal CNS mechanisms.下尿路和胃肠道的神经控制:中枢神经系统的脊髓机制。
Neurourol Urodyn. 2010;29(1):119-27. doi: 10.1002/nau.20841.
5
Interstitial cells in the urinary bladder--localization and function.膀胱间质细胞——定位与功能。
Neurourol Urodyn. 2010;29(1):82-7. doi: 10.1002/nau.20739.
6
Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence.第四届尿失禁国际咨询会:国际科学委员会的建议:尿失禁、盆腔器官脱垂及大便失禁的评估与治疗
Neurourol Urodyn. 2010;29(1):213-40. doi: 10.1002/nau.20870.
7
Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder.膀胱过度活动症患者的心血管发病率、心率和抗毒蕈碱药物的使用。
BJU Int. 2010 Jul;106(2):268-74. doi: 10.1111/j.1464-410X.2009.09073.x. Epub 2009 Nov 17.
8
Patient-reported reasons for discontinuing overactive bladder medication.患者报告的停止治疗膀胱过度活动症的原因。
BJU Int. 2010 May;105(9):1276-82. doi: 10.1111/j.1464-410X.2009.09036.x. Epub 2009 Nov 12.
9
Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study.韩国 EPIC 研究:膀胱过度活动症、尿失禁和下尿路症状的流行情况。
World J Urol. 2011 Apr;29(2):185-90. doi: 10.1007/s00345-009-0490-1. Epub 2009 Nov 8.
10
Transabdominal ultrasonography of detrusor wall thickness in women with overactive bladder.经腹超声测量逼尿肌壁厚度在女性膀胱过度活动症中的应用。
BJU Int. 2010 Mar;105(5):668-72. doi: 10.1111/j.1464-410X.2009.08927.x. Epub 2009 Sep 29.